Effects of low-dose methotrexate with MMI in patients with Graves' disease: results of a randomized clinical trial.

Pu XieLiyun ShenRongguang PengYanqiu WangQinglei YinXinxin ChenZhou JinYanqiu Wang Weiqing Wang Shu Wang Yulin Zhou

Published in: The Journal of clinical endocrinology and metabolism (2024)

Supplemental MTX with MMI resulted in higher discontinuation rate and improvement in decreased TRAb levels to homeostatic levels faster than methimazole treatment alone at months 12-18.

Keyphrases

low dose
high dose
smoking cessation